Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
ProductX CompanyY is a medicine containing an active substance called imatinib. This medicine works by inhibiting the growth of abnormal cells in the diseases listed below. These include some types of cancer.
ProductX CompanyY is a treatment for adults and children for:
ProductX CompanyY is also a treatment for adults for:
In the rest of this leaflet, we will use the abbreviations when talking about these diseases.
If you have any questions about how ProductX CompanyY works or why this medicine has been prescribed for you, ask your doctor.
ProductX CompanyY will only be prescribed to you by a doctor with experience in medicines to treat blood cancers or solid tumours.
Follow all your doctor’s instructions carefully, even if they differ from the general information contained in this leaflet.
If this applies to you, tell your doctor without taking ProductX CompanyY.
If you think you may be allergic but are not sure, ask your doctor for advice.
Talk to your doctor before taking ProductX CompanyY:
If any of these apply to you, tell your doctor before taking ProductX CompanyY.
You may become more sensitive to the sun while taking ProductX CompanyY. It is important to cover sun-exposed areas of skin and use sunscreen with high sun protection factor (SPF). These precautions are also applicable to children.
During treatment with ProductX CompanyY, tell your doctor straight away if you put on weight very quickly. ProductX CompanyY may cause your body to retain water (severe fluid retention).
While you are taking ProductX CompanyY your doctor will regularly check whether the medicine is working. You will also have blood tests and be weighed regularly.
Children and adolescents
ProductX CompanyY is also a treatment for children and adolescents with CML. There is no experience in children with CML below 2 years of age. There is limited experience in children with Ph-positive ALL and very limited experience in children with MDS/MPD, DFSP, GIST and HES/CEL.
Some children and adolescents taking ProductX CompanyY may have slower than normal growth. The doctor will monitor the growth at regular visits.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription (such as paracetamol) and including herbal medicines (such as St. John’s Wort). Some medicines can interfere with the effect of ProductX CompanyY when taken together. They may increase or decrease the effect of ProductX CompanyY, either leading to increased side effects or making ProductX CompanyY less effective. ProductX CompanyY may do the same to some other medicines.
Tell your doctor if you are using medicines that prevent the formation of blood clots.
You may feel dizzy or drowsy or get blurred vision while taking this medicine. If this happens, do not drive or use any tools or machines until you are feeling well again.
Your doctor has prescribed ProductX CompanyY because you suffer from a serious condition. ProductX CompanyY can help you to fight this condition.
However, always take this medicine exactly as your doctor, pharmacist or nurse has told you. It is important that you do this as long as your doctor, pharmacist or nurse tells you to. Check with your doctor, pharmacist or nurse if you are not sure.
Do not stop taking ProductX CompanyY unless your doctor tells you to. If you are not able to take the medicine as your doctor prescribed or you feel you do not need it anymore, contact your doctor straight away.
Use in adults
Your doctor will tell you exactly how many capsules of ProductX CompanyY to take.
Depending on your condition the usual starting dose is either 400 mg or 600 mg:
The starting dose is 400 mg, to be taken as 4 capsules once a day.
For CML and GIST, your doctor may prescribe a higher or lower dose depending on how you respond to the treatment. If your daily dose is 800 mg (8 capsules), you should take 4 capsules in the morning and 4 capsules in the evening.
The starting dose is 600 mg to be taken as 6 capsules once a day.
The starting dose is 400 mg, to be taken as 4 capsules once a day.
The starting dose is 100 mg, to be taken as 1 capsule once a day. Your doctor may decide to increase the dose to 400 mg, to be taken as 4 capsules once a day, depending on how you respond to treatment.
The dose is 800 mg per day (8 capsules), to be taken as 4 capsules in the morning and 4 capsules in the evening.
The doctor will tell you how many capsules of ProductX CompanyY to give to your child. The amount of ProductX CompanyY given will depend on your child’s condition, body weight and height. The total daily dose in children and adolescents must not exceed 800 mg with CML and 600 mg with Ph+ALL. The treatment can either be given to your child as a once‑daily dose or alternatively the daily dose can be split into two administrations (half in the morning and half in the evening).
Keep taking ProductX CompanyY every day for as long as your doctor tells you.
If you have accidentally taken too many capsules, talk to your doctor straight away. You may require medical attention. Take the medicine pack with you.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them. They are usually mild to moderate.
Some side effects may be serious. Tell your doctor straight away if you get any of the following:
Very common (may affect more than 1 in 10 people) or common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people) or rare (may affect up to 1 in 1,000 people):
Not known (frequency cannot be estimated from the available data):
If you get any of the above, tell your doctor straight away.
Other side effects may include:
Very common (may affect more than 1 in 10 people):
If any of these affects you severely, tell your doctor.
Common (may affect up to 1 in 10 people):
If any of these affects you severely, tell your doctor.
Uncommon (may affect up to 1 in 100 people):
If any of these affects you severely, tell your doctor.
Rare (may affect up to 1 in 1,000 people):
If any of these affects you severely, tell your doctor.
Not known (frequency cannot be estimated from the available data):
If any of these affects you severely, tell your doctor.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of the month.
This medicine does not require any special storage conditions.
Do not use any pack that is damaged or shows signs of tampering.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
ProductX CompanyY 100 mg hard capsules are non transparent orange capsules with black marking 7629 on capsule body and black marking TEVA on capsule cap. The content of the capsule is white to light yellow granulated powder. The capsules are approximately 19 mm long and 7 mm wide.
ProductX CompanyY 100 mg hard capsules are available in pack sizes of 60 or 120 hard capsules in blisters.
ProductX CompanyY 100 mg hard capsules are available in pack sizes of 20x1, 60x1, 120x1 or 180x1 hard capsules in perforated unit dose blisters.
Not all pack sizes may be marketed.
CompanyY B.V.
Swensweg 5
2031 GA Haarlem
The Netherlands
Manufacturer
CompanyY Pharmaceutical Works Private Limited Company
Pallagi út 13
Debrecen H-4042
Hungary
CompanyY Czech Industries s.r.o.
Ostravska 29, c.p. 305
74770 Opava-Komarov
Czech Republic
TEVA PHARMA, S.L.U.
C/C, n. 4, Poligono Industrial Malpica
50016 Zaragoza
Spain
Merckle GmbH
Graf-Arco-Str. 3, 89079 Ulm
Germany
CompanyY Operations Poland Sp. z o.o.
ul. Mogilska 80, 31-546 Krakow
Poland
CompanyY Pharma B.V.
Swensweg 5,
2031 GA Haarlem
The Netherlands
PLIVA Croatia Ltd.
Prilaz baruna Filipovica 25
10000 Zagreb
Croatia
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
België/Belgique/Belgien CompanyY Pharma Belgium N.V./S.A./AG Tél/Tel: +32 38207373
|
Lietuva UAB CompanyY Baltics Tel: +370 52660203
|
България Тева Фарма ЕАД Teл: +359 24899585
|
Luxembourg/Luxemburg CompanyY Pharma Belgium N.V./S.A./AG Belgique/Belgien Tél/Tel: +32 38207373
|
Česká republika CompanyY Pharmaceuticals CR, s.r.o. Tel: +420 251007111
|
Magyarország CompanyY Gyógyszergyár Zrt. Tel: +36 12886400
|
Danmark CompanyY Denmark A/S Tlf: +45 44985511
|
Malta CompanyY Pharmaceuticals Ireland L-Irlanda Tel: +44 2075407117
|
Deutschland AbZ-Pharma GmbH Tel: +49 73140205
|
Nederland CompanyY Nederland B.V. Tel: +31 8000228400
|
Eesti UAB CompanyY Baltics Eesti filiaal Tel: +372 6610801
|
Norge CompanyY Norway AS Tlf: +47 66775590
|
Ελλάδα TEVA HELLAS Α.Ε. Τηλ: +30 2118805000
|
Österreich ratiopharm Arzneimittel Vertriebs-GmbH Tel: +43 1970070
|
España CompanyY Pharma, S.L.U. Tel: +34 913873280
|
Polska CompanyY Pharmaceuticals Polska Sp. z o.o. Tel: +48 223459300
|
France CompanyY Santé Tél: +33 155917800
|
Portugal CompanyY Pharma - Produtos Farmacêuticos, Lda. Tel: +351 214767550
|
Hrvatska Pliva Hrvatska d.o.o. Tel: +385 13720000
|
România CompanyY Pharmaceuticals S.R.L. Tel: +40 212306524
|
Ireland CompanyY Pharmaceuticals Ireland Tel: +44 2075407117 |
Slovenija Pliva Ljubljana d.o.o. Tel: +386 15890390 |
Ísland CompanyY Pharma Iceland ehf. Sími: +354 5503300
|
Slovenská republika TEVA Pharmaceuticals Slovakia s.r.o. Tel: +421 257267911
|
Italia CompanyY Italia S.r.l. Tel: +39 028917981
|
Suomi/Finland CompanyY Finland Oy Puh/Tel: +358 201805900
|
Κύπρος TEVA HELLAS Α.Ε. Ελλάδα Τηλ: +30 2118805000
|
Sverige CompanyY Sweden AB Tel: +46 42121100
|
Latvija UAB CompanyY Baltics filiāle Latvijā Tel: +371 67323666
|
United Kingdom (Northern Ireland) CompanyY Pharmaceuticals Ireland Ireland Tel: +44 2075407117
|
Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu